TOP 20 Top 20 Biopharma Deal Terminations of 2022 Based on Total Deal ValueByPrince GiriMarch 22, 20230Comments
INSIGHTS+ Top Performing Drug of 2021 – Darzalex (March Edition)BySenior EditorMarch 21, 20230Comments
VIEWPOINTS Craig Thompson, CEO of Cerevance Shares Insights from the Preclinical Data Presented at the Society for Neuroscience (SFN) 2022BySenior EditorMarch 20, 20230Comments
THOUGHTSPOT Silicon Valley Bank Collapse: Implications on Life Science IndustryBySaurabh ChaubeyMarch 20, 20230Comments
VIEWPOINTS Andrea Mugan, Global Franchise Head of DDR & GYN/GU Cancers, AstraZeneca Shares Insights from the Launch of Digital Patient Support Resource for Ovarian Cancer PatientsBySenior EditorMarch 16, 20230Comments
INSIGHTS+ Insights+: The US FDA New Drug Approvals in February 2023BySenior EditorMarch 15, 20230Comments
THOUGHTSPOT Getting on with Rare Disease Therapeutic Options (Orphan Disease Therapies)BySaurabh ChaubeyMarch 14, 20230Comments
